Evaluation of a Rapid Point-of-Care Serological Triage Test for Active TB

Launched by NORWEGIAN INSTITUTE OF PUBLIC HEALTH · Feb 9, 2021

Keywords

ClinConnect Summary

This clinical trial is studying a new quick test called SeroSelectTB that aims to help doctors identify active tuberculosis (TB) illness more easily and quickly at local healthcare centers in countries like South Africa, Tanzania, and Ethiopia. The goal is to see how well this test works in diagnosing TB, which can help reduce the time it takes to get a diagnosis and start treatment, potentially lowering the spread of the disease. Participants in the study will provide blood and saliva samples, as well as sputum (a mixture of saliva and mucus) for routine TB testing.

To join the trial, you need to be 18 years or older, sign a consent form, and be feeling unwell with a suspicion of having TB or pneumonia. However, if you are currently being treated for TB or have taken TB treatment in the past month, you won't be eligible to participate. If you decide to take part, you can expect to help advance our understanding of TB diagnosis, which could lead to better healthcare solutions for many people suffering from this disease.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 18 years of age or older
• • Informed Consent Form signed
• • Unwell, suspected to have TB or pneumonia
• Exclusion Criteria:
• • Currently receiving TB treatment
• • On TB treatment past 30 days or more, or last dose less than 1 month before enrolment